The clinical assessment of 30-day mortality in patients with ischemic stroke or hemorrhagic stroke can be conducted using various ratios, including neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio, neutrophil/albumin ratio, prognostic nutritional index (PNI), systemic immune inflammation index (SII), and red cell distribution width/albumin ratio (RA) (17–19). The gene discussed is ALB; the disease is hemorrhagic stroke.